Evidence map›Paper›PMID 38165331›Full record

ArticleNeurology2024

Association of Poor Oral Health With Neuroimaging Markers of White Matter Injury in Middle-Aged Participants in the UK Biobank.

Cyprien A Rivier, Daniela B Renedo, Adam de Havenon, N Abimbola Sunmonu, Thomas M Gill, Seyedmehdi Payabvash, Kevin N Sheth, Guido J Falcone

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cyprien A RivierFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0002-1148-1829
Daniela B RenedoFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0003-4120-6649
Adam de HavenonFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0001-8178-8597
N Abimbola SunmonuFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.
Thomas M GillFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0002-6450-0368
Seyedmehdi PayabvashFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0003-4628-0370
Kevin N ShethFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0003-2003-5473
Guido J FalconeFrom the Departments of Neurology (C.A.R., D.B.R., A.d.H., N.A.S., K.N.S., G.J.F.), Internal Medicine (T.M.G.), and Radiology (S.P.), Yale University School of Medicine; and Yale Center for Brain and Mind Health (C.A.R., A.d.H., S.P., K.N.S., G.J.F.), New Haven, CT.ORCID 0000-0002-6407-0302
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Lauren Ferrante · 2002 to 2026
$37.9M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · PI Adam H. de Havenon · 2023 to 2026
$2.0M
Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRIK23NS105924 · NINDS · YALE UNIVERSITY · PI DE HAVENON, ADAM H. · 2019 to 2023
$988k
NCATS NIH HHS UL1 TR001863NIA NIH HHS P30 AG021342NINDS NIH HHS K23 NS105924NINDS NIH HHS R01 NS130189
6 · The paper itself

Abstract

BACKGROUND AND

objectivesPoor oral health is a modifiable risk factor that is associated with clinically observed cardiovascular disease. However, the relationship between oral and brain health is not well understood. We tested the hypothesis that poor oral health is associated with worse neuroimaging brain health profiles in middle-aged persons without stroke or dementia.

methodsWe performed a 2-stage cross-sectional neuroimaging study using UK Biobank data. First, we tested for association between self-reported poor oral health and MRI neuroimaging markers of brain health. Second, we used Mendelian randomization (MR) analyses to test for association between genetically determined poor oral health and the same neuroimaging markers. Poor oral health was defined as the presence of dentures or loose teeth. As instruments for the MR analysis, we used 116 independent DNA sequence variants linked to increased composite risk of dentures or teeth that are decayed, missing, or filled. Neuroimaging markers of brain health included white matter hyperintensity (WMH) volume and aggregate measures of fractional anisotropy (FA) and mean diffusivity (MD), 2 metrics indicative of white matter tract disintegrity obtained through diffusion tensor imaging across 48 brain regions.

resultsWe included 40,175 persons (mean age 55 years, female sex 53%) enrolled from 2006 to 2010, who underwent a dedicated research brain MRI between 2014 and 2016. Among participants, 5,470 (14%) had poor oral health. Poor oral health was associated with a 9% increase in WMH volume (β = 0.09, SD = 0.014, DISCUSSION: Among middle age Britons without stroke or dementia, poor oral health was associated with worse neuroimaging brain health profiles. Genetic analyses confirmed these associations, supporting a potentially causal association. Because the neuroimaging markers evaluated in this study precede and are established risk factors of stroke and dementia, our results suggest that oral health, an easily modifiable process, may be a promising target for very early interventions focused on improving brain health.

Indexed as

DementiaStrokeWhite MatterBiological Specimen BanksCross-Sectional StudiesDiffusion Tensor ImagingFemaleHumansMaleMiddle AgedNeuroimagingOral HealthUK Biobank

Identifiers

PMID38165331
PMCPMC10870735
OpenAlexW4390037200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.